Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Director/PDMR Shareholding

11 Sep 2019 15:49

RNS Number : 0249M
Arden Partners plc
11 September 2019
 

Arden Partners plc

("Arden" or the "Group")

 

Director/PDMR Shareholding

 

Arden Partners plc announces that on the 10 September 2019 the Trustees of the Arden Partners plc Share Incentive Plan acquired 76,766 ordinary shares (comprising 38,383 Partnership shares and 38,383 Matching shares) for the benefit of the participants of the Plan. The price paid by the participants was 19 pence per share. The Partnership shares will be used to satisfy employees' contributions to the Plan deducted from their August salary. The Matching shares are purchased for the employees' benefit by the Group and are subject to certain eligibility criteria. 

 

Directors of Arden Partners plc, as contributors to the plan, have acquired the following interests in the shares:-

 

 

Name

 

Partnership

 

Matching

Total

Partnership

Total

Matching

James Reed-Daunter

789

789

7,928

7,928

Steve Douglas

9,473

9,473

14,210

14,210

 

For further information, please contact:

Steve Wassell

Company Secretary

0121 423 8993

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

 James Reed-Daunter

 

2

 

Reason for the notification

a)

 

Position/status

Executive Director

b)

Initial notification /Amendment

September 11th, 2019

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Arden Partners plc

b)

LEI

213800KRNTZFOY1DA806

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary 10p Shares

Identification code

GB00B15CTY44

b)

Nature of the transaction

Purchase

c)

Price(s) and volume(s)

Price(s)

Volume(s)

0.19p

789

d)

Aggregated information

- Aggregated volume

789

- Price

0.19p

e)

Date of the transaction

September 10th, 2019

f)

Place of the transaction

AIMX

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

 Steve Douglas

 

2

 

Reason for the notification

a)

 

Position/status

Group Finance Director

b)

Initial notification /Amendment

September 11th, 2019

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Arden Partners plc

b)

LEI

213800KRNTZFOY1DA806

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary 10p Shares

Identification code

GB00B15CTY44

b)

Nature of the transaction

Purchase

c)

Price(s) and volume(s)

Price(s)

Volume(s)

0.19p

9,473

d)

Aggregated information

- Aggregated volume

9,473

- Price

0.19p

e)

Date of the transaction

September 10th, 2019

f)

Place of the transaction

AIMX

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFSSARILLIA
Date   Source Headline
22nd Jan 201011:17 amRNSEPT Disclosure
20th Jan 201010:46 amRNSEPT Disclosure
11th Jan 201011:32 amRNSEPT Disclosure
7th Jan 201011:53 amRNSEPT Disclosure
5th Jan 201011:01 amRNSEPT Disclosure
4th Jan 201011:24 amRNSEPT Disclosure
31st Dec 200910:04 amRNSEPT Disclosure
23rd Dec 200911:46 amRNSEPT Disclosure
22nd Dec 200911:09 amRNSEPT Disclosure
21st Dec 200911:46 amRNSEPT Disclosure
18th Dec 20093:59 pmRNSEPT Disclosure
11th Dec 200911:30 amRNSEPT Disclosure
26th Nov 200911:59 amRNSEPT Disclosure
25th Nov 200911:40 amRNSEPT Disclosure
23rd Nov 200910:07 amRNSBlocklisting Return
16th Nov 200910:29 amRNSEPT Disclosure
2nd Nov 200911:38 amRNSTotal Voting Rights
14th Sep 20094:08 pmRNSEBT purchase
4th Sep 200911:20 amRNSEPT Disclosure
1st Sep 20091:59 pmRNSTotal Voting Rights
1st Sep 200910:31 amRNSEPT Disclosure
25th Aug 200910:01 amRNSEPT Disclosure
20th Aug 200911:23 amRNSEPT Disclosure
19th Aug 200911:29 amRNSEPT Disclosure
18th Aug 200910:24 amRNSEPT Disclosure
14th Aug 200910:21 amRNSEPT Disclosure
13th Aug 200911:28 amRNSEPT Disclosure
11th Aug 200911:41 amRNSEPT Disclosure - Amendment
11th Aug 200911:24 amRNSEPT Disclosure
10th Aug 20099:47 amRNSEPT Disclosure
6th Aug 20099:47 amRNSEPT Disclosure
5th Aug 200910:48 amRNSEPT Disclosure
31st Jul 20099:29 amRNSEPT Disclosure
30th Jul 200910:45 amRNSEPT Disclosure
24th Jul 20091:16 pmRNSDirector's dealing
24th Jul 200910:08 amRNSEPT Disclosure
23rd Jul 20099:19 amRNSEPT Disclosure
17th Jul 20091:44 pmRNSEBT Purchase
14th Jul 20097:00 amRNSInterim results
10th Jul 200910:08 amRNSEPT Disclosure
9th Jul 20099:56 amRNSEPT Disclosure
3rd Jul 20097:00 amRNSNotice of Results
1st Jul 20099:31 amRNSEPT Disclosure
25th Jun 20099:52 amRNSEPT Disclosure
24th Jun 200911:01 amRNSEPT Disclosure
23rd Jun 200910:17 amRNSEPT Disclosure
15th Jun 200912:13 pmRNSAndrew Heath Appointed Head of Equities
12th Jun 200910:43 amRNSEPT Disclosure
11th Jun 200910:15 amRNSEPT Disclosure
10th Jun 200910:26 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.